CoChat
Sign Up
Cited by 102Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesMental Health Treatment and Access

The DOI matches its Crossref record; 111 of the 113 references it cites were found in a registry or an index.

Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses

Goldner, Elliot M., Lusted, Anna, Roerecke, Michael, Rehm, Jürgen, Fischer, Benedikt·2014·Addictive Behaviors
DOI 10.1016/j.addbeh.2013.11.022
Open this paper in CoChat — free account

Abstract

Non-medical prescription opioid use (NMPOU) constitutes a substantial clinical and public health concern in North America. Although there is evidence of elevated rates of mental health problems among people with NMPOU, the extent of these correlations specifically in treatment samples has not been systematically assessed. A systematic review and meta-analysis were conducted for Axis-1 psychiatric diagnoses and symptoms with a principal focus on depression and anxiety disorders in substance use treatment samples reporting NMPOU at admission to treatment (both criteria within past 30days). 11 unique studies (all from either the United States or Canada) met inclusion criteria and were included in the meta-analysis. The pooled prevalence of 'any' mental health problems (both diagnosis and symptoms) among substance abuse treatment patients reporting NMPOU was 43% (95% CI: 32%-54%; I(2) for inter-study heterogeneity: 99.5%). The pooled prevalence of depression diagnosis among substance abuse treatment patients reporting NMPOU was 27% (95% CI: 9%-45%; I(2): 99.2%); the pooled prevalence of anxiety diagnosis in the sample was 29% (95% CI: 14%-44%; I(2): 98.7%). The prevalence rates of psychiatric problems (both diagnosis and symptoms), depression diagnosis and anxiety diagnosis are disproportionately high in substance use treatment samples reporting NMPOU relative to general population rates. Adequate and effective clinical strategies are needed to address co-occurring NMPOU and mental health in substance use treatment systems, especially given rising treatment demand for NMPOU. Efforts are needed to better understand the temporal and causal relationships among NMPOU, mental health problems, and treatment seeking in order to improve interventions.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.addbeh.2013.11.022

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 113 references

2 of the 113 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 101–102 of 102

Related

See all

Metadata

Authors
Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B.
Affiliations
  • Simon Fraser University (CA)
  • Centre for Addiction and Mental Health (CA)
Corresponding author
Fischer, Benedikt
ORCID
Venue
Addictive Behaviors
Publisher
Elsevier BV
Published
2014-03
Volume
39
Issue
3
Pages
520-531
ISSN
0306-4603 (ISSN-L)
DOI
10.1016/j.addbeh.2013.11.022
OpenAlex
W1995094141
Cited by
102
References
113
Citations by year
2026: 5 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 15 · 2020: 10 · 2019: 16 · 2018: 9 · 2017: 9 · 2016: 6 · 2015: 7 · 2014: 2
FWCI
0.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Addictive Behaviors (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (SAF94814, 108448_1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
prescription opioid misuse, opioid misuse, depression, anxiety disorders, psychiatric comorbidity, addiction treatment, prevalence, mental illness, co-occurring disorders
MeSH terms
Anxiety, Anxiety Disorders, Mental Disorders, Depression, Depressive Disorder, Humans, Opioid-Related Disorders, Prevalence, Diagnosis, Dual (Psychiatry)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review